Email gets to the heart of the mystery of the continuing corporate silence. In my opinion the ‘complete vaccine’ has always been a long shot. Not so Olaregen, which back in May 2021 was ramping up production and sales of FDA approved...approved!...Excellagen, a superstar product with all manner of applications. This alone would scrape the share price off the floor. A longer shot was Altucell, which was moving into human trials with EU approval and support. Likewise the cancer vaccines going into trials in China. Are we supposed to believe that there has been no progress in any of these departments? Really?
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links